Literature DB >> 32688269

Risk factors and biomarkers of severe dengue.

Abhay Ps Rathore1, Farouk S Farouk2, Ashley L St John3.   

Abstract

Dengue virus infects several million people each year. Although usually a self-limiting disease, some patients can develop life-threatening severe complications, characterized by plasma leakage, hemorrhaging, and shock. The signs and symptoms of severe disease usually arise late in the disease course when patients are recovering and fever has subsided, making it difficult to predict. Efforts are underway to identify risk factors and biomarkers that can accurately predict disease severity in the acute febrile phase of the disease, facilitating early intervention and treatment strategies for those at greatest risk. In this review we discuss recent advancements in identifying risk factors and biomarkers for the prognosis of severe dengue.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32688269     DOI: 10.1016/j.coviro.2020.06.008

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  7 in total

Review 1.  Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.

Authors:  Anna P Durbin
Journal:  Curr Opin Virol       Date:  2020-10-23       Impact factor: 7.090

2.  Severe dengue in adults and children, Ouagadougou (Burkina Faso), West Africa, October 2015-January 2017.

Authors:  Apoline Kongnimissom Sondo; Eric Arnaud Diendéré; Bertrand Ivlabehire Meda; Ismaèl Diallo; Jacques Zoungrana; Armel Poda; Noel Magloire Manga; Brice Bicaba; Arouna Gnamou; Charles Joel Kagoné; Guetawendé Sawadogo; Issaka Yaméogo; Noelle A Benzekri; Zekiba Tarnagda; Séni Kouanda; Ramata Ouédraogo-Traoré; Macaire S Ouédraogo; Moussa Seydi
Journal:  IJID Reg       Date:  2021-10-04

3.  Mono-(2-ethylhexyl) phthalate Promotes Dengue Virus Infection by Decreasing IL-23-Mediated Antiviral Responses.

Authors:  Chun-Yu Lin; Chung-Hao Huang; Wen-Hung Wang; Jyrki Tenhunen; Ling-Chien Hung; Chi-Chou Lin; Yu-Cheng Chen; Yen-Hsu Chen; Wei-Ting Liao
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

4.  Assessment of the Risk of Severe Dengue Using Intrahost Viral Population in Dengue Virus Serotype 2 Patients via Machine Learning.

Authors:  Su-Jhen Hung; Huey-Pin Tsai; Ya-Fang Wang; Wen-Chien Ko; Jen-Ren Wang; Sheng-Wen Huang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

5.  Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis.

Authors:  Tran Quang Thach; Heba Gamal Eisa; AlMotsim Ben Hmeda; Hazem Faraj; Tieu Minh Thuan; Manal Mahmoud Abdelrahman; Mario Gerges Awadallah; Nam Xuan Ha; Michael Noeske; Jeza Muhamad Abdul Aziz; Nguyen Hai Nam; Mohamed El Nile; Shyam Prakash Dumre; Nguyen Tien Huy; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2021-10-05

6.  Maternal Immunity and Vaccination Influence Disease Severity in Progeny in a Novel Mast Cell-Deficient Mouse Model of Severe Dengue.

Authors:  Chinmay Kumar Mantri; Gayathri Soundarajan; Wilfried A A Saron; Abhay P S Rathore; Sylvie Alonso; Ashley L St John
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

7.  Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes.

Authors:  Nguyen Lam Vuong; Phung Khanh Lam; Damien Keng Yen Ming; Huynh Thi Le Duyen; Nguyet Minh Nguyen; Dong Thi Hoai Tam; Kien Duong Thi Hue; Nguyen Vv Chau; Ngoun Chanpheaktra; Lucy Chai See Lum; Ernesto Pleités; Cameron P Simmons; Kerstin D Rosenberger; Thomas Jaenisch; David Bell; Nathalie Acestor; Christine Halleux; Piero L Olliaro; Bridget A Wills; Ronald B Geskus; Sophie Yacoub
Journal:  Elife       Date:  2021-06-22       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.